NASDAQ:MYNZ Mainz Biomed (MYNZ) Stock Price, News & Analysis $0.34 -0.02 (-5.62%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.32▼$0.3650-Day Range$0.34▼$0.8752-Week Range$0.32▼$4.71Volume1.21 million shsAverage Volume344,503 shsMarket Capitalization$4.03 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Get Mainz Biomed alerts: Email Address Mainz Biomed MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside1,686.8% Upside$6.00 Price TargetShort InterestHealthy4.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.49Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.65 out of 5 stars 3.3 Analyst's Opinion Consensus RatingMainz Biomed has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageMainz Biomed has received no research coverage in the past 90 days.Read more about Mainz Biomed's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.79% of the float of Mainz Biomed has been sold short.Short Interest Ratio / Days to CoverMainz Biomed has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mainz Biomed has recently increased by 111.68%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMainz Biomed does not currently pay a dividend.Dividend GrowthMainz Biomed does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MYNZ. Previous Next 3.0 News and Social Media Coverage News SentimentMainz Biomed has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Mainz Biomed this week, compared to 2 articles on an average week.Search Interest3 people have searched for MYNZ on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Mainz Biomed to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Mainz Biomed insiders have not sold or bought any company stock.Percentage Held by Insiders18.20% of the stock of Mainz Biomed is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Mainz Biomed's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Mainz Biomed is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mainz Biomed is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMainz Biomed has a P/B Ratio of 1.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Mainz Biomed's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Mainz Biomed Stock (NASDAQ:MYNZ)Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.Read More MYNZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MYNZ Stock News HeadlinesJuly 25 at 8:49 PM | markets.businessinsider.comEQS-News: Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User ConvenienceJuly 25 at 8:01 AM | globenewswire.comMainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User ConvenienceJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 20, 2024 | americanbankingnews.comMainz Biomed (NASDAQ:MYNZ) Shares Down 8.2% July 19, 2024 | nz.finance.yahoo.comMainz Biomed BV (4TO.DU)July 9, 2024 | benzinga.comWhy Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving PremarketJuly 9, 2024 | globenewswire.comMainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening TestJuly 2, 2024 | globenewswire.comMainz Biomed Provides Half Year 2024 Corporate UpdateJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.June 3, 2024 | globenewswire.comMainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024May 31, 2024 | globenewswire.comMainz Biomed Reports Results of 2024 Annual General MeetingMay 28, 2024 | finanznachrichten.deEQS-News: Mainz BioMed N.V.: Mainz Biomed präsentiert neue gepoolte Daten seiner bisher größten Darmkrebs-Screening-Studie auf der ASCO 2024May 28, 2024 | globenewswire.comMainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual MeetingMay 20, 2024 | globenewswire.comMainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA TrialMay 7, 2024 | finanznachrichten.deEQS-News: Mainz BioMed N.V.: Mainz Biomed präsentiert Ergebnisse der Darmkrebsfrüherkennungsstudie eAArly DETECT auf der Digestive Disease Week 2024May 7, 2024 | globenewswire.comMainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.April 30, 2024 | uk.news.yahoo.comStrictly Come Dancing's Shirley Ballas shares important cancer update to fansApril 25, 2024 | globenewswire.comMainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer DiagnosticSee More Headlines Receive MYNZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mainz Biomed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/15/2023Today7/26/2024Next Earnings (Estimated)8/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MYNZ CUSIPN/A CIK1874252 Webmainzbiomed.com Phone49-6131-554-2860FaxN/AEmployees30Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$9.00 Low Stock Price Target$3.00 Potential Upside/Downside+1,686.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-26,300,000.00 Net Margins-2,934.82% Pretax Margin-2,938.10% Return on Equity-488.05% Return on Assets-145.77% Debt Debt-to-Equity Ratio0.36 Current Ratio0.97 Quick Ratio0.91 Sales & Book Value Annual Sales$900,000.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.27 per share Price / Book1.24Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.14 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Guido Baechler (Age 59)CEO & Executive Director Mr. William J. Caragol (Age 57)Chief Financial Officer Dr. Christopher Von Torne P.M.P. (Age 52)Ph.D., Chief Operating Officer Dr. Frank Krieg-Schneider (Age 62)Chief Technology Officer Dr. Moritz Eidens Ph.D. (Age 40)Chief Science Officer & Executive Director Stefan ErlachHead of Human ResourcesMr. Philipp Freese (Age 41)Chief Business Officer Mr. Darin S. Leigh (Age 56)Chief Commercial Officer More ExecutivesKey CompetitorsAesther Healthcare AcquisitionNASDAQ:AEHAWAlvotechNASDAQ:ALVOWAtlantic Coastal Acquisition Corp. IINASDAQ:ACABWBioLingus (Cayman)NASDAQ:SUBLCassava SciencesNASDAQ:SAVAWView All Competitors MYNZ Stock Analysis - Frequently Asked Questions How have MYNZ shares performed this year? Mainz Biomed's stock was trading at $1.16 on January 1st, 2024. Since then, MYNZ stock has decreased by 71.1% and is now trading at $0.3358. View the best growth stocks for 2024 here. How were Mainz Biomed's earnings last quarter? Mainz Biomed (NASDAQ:MYNZ) announced its quarterly earnings data on Tuesday, August, 15th. The company reported ($0.56) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by $0.14. The company earned $0.25 million during the quarter, compared to the consensus estimate of $0.25 million. Mainz Biomed had a negative net margin of 2,934.82% and a negative trailing twelve-month return on equity of 488.05%. When did Mainz Biomed IPO? Mainz Biomed (MYNZ) raised $10 million in an initial public offering on Friday, November 5th 2021. The company issued 2,000,000 shares at a price of $4.00-$6.00 per share. Boustead Securities acted as the underwriter for the IPO. How do I buy shares of Mainz Biomed? Shares of MYNZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MYNZ) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mainz Biomed Please log in to your account or sign up in order to add this asset to your watchlist. Share Mainz Biomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
